Literature DB >> 8225569

Antigenic stability of Borrelia burgdorferi during chronic infections of immunocompetent mice.

S W Barthold1.   

Abstract

Mice were actively immunized by intradermal inoculation with 10(4) cloned Borrelia burgdorferi bacteria and then cured of the B. burgdorferi infection with an antibiotic after 90 days. They were resistant to intradermal 10(2)- or 10(4)-bacterium challenge infection with either the original cloned B. burgdorferi or B. burgdorferi isolated from each punch biopsies at 90 days of infection (prior to antibiotic treatment), including autologous B. burgdorferi isolates. In contrast, sham-infected (nonimmune) mice were susceptible to challenge infection with both early and late B. burgdorferi isolates. Since there was a potential for in vitro modification of the spirochetes during the 2-week culture period which would obscure results, an alternate means of challenge infection, using tissue transplants, was implemented. By using the same approach, mice were immunized by infection, treated with antibiotics, but challenged by subcutaneous transplantation of ear skin pieces biopsied and frozen prior to antibiotic treatment. Mice were infected for 15, 90, or 180 days before biopsy and antibiotic treatment and then transplant challenged with autologous infected tissue. Sham-immunized mice received infected tissue, and immune mice received uninfected tissue as controls. Mice infected for only 15 days, but not mice infected for 90 or 180 days, could be reinfected by autografts, whereas nonimmune mice became infected with tissues collected at each of these intervals and immune mice transplanted with normal skin were uninfected. These results indicate that immunity to B. burgdorferi is effective against the original inoculum, late isolates of the spirochete, or infected tissues collected at intervals of up to 180 days, suggesting that there is no significant antigenic change in B. burgdorferi during chronic infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225569      PMCID: PMC281269          DOI: 10.1128/iai.61.12.4955-4961.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.

Authors:  S W Barthold; D H Persing; A L Armstrong; R A Peeples
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

2.  Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B.

Authors:  E Fikrig; H Tao; F S Kantor; S W Barthold; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

3.  Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans.

Authors:  E Asbrink; A Hovmark
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1985-04

4.  Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.

Authors:  S W Barthold; L K Bockenstedt
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer.

Authors:  E Asbrink; A Hovmark; B Hederstedt
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

6.  Chronic Lyme borreliosis in the laboratory mouse.

Authors:  S W Barthold; M S de Souza; J L Janotka; A L Smith; D H Persing
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Experimental Lyme disease in dogs produces arthritis and persistent infection.

Authors:  M J Appel; S Allan; R H Jacobson; T L Lauderdale; Y F Chang; S J Shin; J W Thomford; R J Todhunter; B A Summers
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

8.  The histopathology of experimentally infected hamsters with the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  P H Duray; R C Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1986-02

9.  Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.

Authors:  U E Schaible; L Gern; R Wallich; M D Kramer; M Prester; M M Simon
Journal:  Immunol Lett       Date:  1993-05       Impact factor: 3.685

10.  Isolation and cultivation of Lyme disease spirochetes.

Authors:  A G Barbour
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  23 in total

1.  Duration of immunity to reinfection with tick-transmitted Borrelia burgdorferi in naturally infected mice.

Authors:  J Piesman; M C Dolan; C M Happ; B J Luft; S E Rooney; T N Mather; W T Golde
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato species.

Authors:  S W Barthold
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.

Authors:  Artem S Rogovskyy; David C Gillis; Yurij Ionov; Ekaterina Gerasimov; Alex Zelikovsky
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

4.  Population dynamics of a naturally occurring heterogeneous mixture of Borrelia burgdorferi clones.

Authors:  E K Hofmeister; G E Glass; J E Childs; D H Persing
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.

Authors:  Stephen W Barthold; Emir Hodzic; Denise M Imai; Sunlian Feng; Xiaohua Yang; Benjamin J Luft
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

6.  Tick transmission of Borrelia burgdorferi to inbred strains of mice induces an antibody response to P39 but not to outer surface protein A.

Authors:  W T Golde; K J Kappel; G Dequesne; C Feron; D Plainchamp; C Capiau; Y Lobet
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Variation in antigenicity and infectivity of derivatives of Borrelia burgdorferi, strain B31, maintained in the natural, zoonotic cycle compared with maintenance in culture.

Authors:  W T Golde; M C Dolan
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice.

Authors:  K D Moody; R L Adams; S W Barthold
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

9.  Evidence for strain-specific immunity in patients treated for early lyme disease.

Authors:  Camilo E Khatchikian; Robert B Nadelman; John Nowakowski; Ira Schwartz; Gary P Wormser; Dustin Brisson
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

10.  OspC-independent infection and dissemination by host-adapted Borrelia burgdorferi.

Authors:  Kit Tilly; Aaron Bestor; Daniel P Dulebohn; Patricia A Rosa
Journal:  Infect Immun       Date:  2009-04-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.